Skip to main content
. 2017 Aug 4;16(4):4537–4544. doi: 10.3892/mmr.2017.7177

Figure 5.

Figure 5.

Telmisartan decreases the levels of Smad3 and p-Smad3. (A) Expression of Smad3 was assessed by immunohistochemistry (magnification, ×200) and (B) optical density was analyzed using Image-Pro Plus 6.0. (C) Western blot analysis revealed that telmisartan effectively decreased the level of (D) Smad3, and inhibited its activation by decreasing the level of (E) p-Smad3. Data are presented as the mean ± standard deviation. #P<0.05, vs. WKY; *P<0.05, vs. SHR. Smad3, small mothers against decapentaplegic 3; p-Smad3, phosphorylated Smad3; WKY, Wistar-Kyoto rats; SHR, spontaneously hypertensive rats.